
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Celcuity Inc is clinical-stage biotechnology company seeking to extend the lives of cancer patients by pursuing an integrated therapeutic (Rx) and companion diagnostic (CDx) strategy. The company's drug candidate, gedatolisib, is a potent, well-tolerated, small molecule dual inhibitor, administered ... Celcuity Inc is clinical-stage biotechnology company seeking to extend the lives of cancer patients by pursuing an integrated therapeutic (Rx) and companion diagnostic (CDx) strategy. The company's drug candidate, gedatolisib, is a potent, well-tolerated, small molecule dual inhibitor, administered intravenously, that selectively targets all class I isoforms of PI3K and mammalian target of rapamycin (mTOR). Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.07 | 0.581395348837 | 12.04 | 13.4 | 12.04 | 150382 | 12.83118647 | CS |
4 | 1.65 | 15.7743785851 | 10.46 | 13.4 | 10.26 | 137199 | 11.58575195 | CS |
12 | 1.76 | 17.0048309179 | 10.35 | 13.4 | 7.575 | 240089 | 10.17820024 | CS |
26 | -0.45 | -3.58280254777 | 12.56 | 13.91 | 7.575 | 256033 | 10.98118833 | CS |
52 | -2.92 | -19.4278110446 | 15.03 | 19.77 | 7.575 | 286169 | 13.70132616 | CS |
156 | 4.57 | 60.6100795756 | 7.54 | 22.188 | 7.46 | 164620 | 13.65798709 | CS |
260 | 4.41 | 57.2727272727 | 7.7 | 33.01 | 4.81 | 134966 | 15.33512364 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions